Neurotoxic effects induced by the Drosophila amyloid-β peptide suggest a conserved toxic function

被引:90
作者
Carmine-Simmen, Katia [1 ]
Proctor, Thomas [1 ]
Tschaepe, Jakob [1 ]
Poeck, Burkhard [2 ]
Triphan, Tilman [2 ]
Strauss, Roland [2 ]
Kretzschmar, Doris [1 ]
机构
[1] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA
[2] Univ Wurzburg, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany
关键词
APP; APPL; Drosophila; Amyloid; Neurodegeneration; beta-secretase; Behavioral deficits; FAMILIAL ALZHEIMERS-DISEASE; PROTEIN-PRECURSOR; CAENORHABDITIS-ELEGANS; A-BETA; TRANSGENIC DROSOPHILA; PRESENILIN HOMOLOG; NEURODEGENERATION; GENE; MODEL; ACCUMULATION;
D O I
10.1016/j.nbd.2008.10.014
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
The accumulation of amyloid-beta (A beta) into plaques is a hallmark feature of Alzheimer's disease (AD). While amyloid precursor protein (APP)-related proteins are found in most organisms, only V fragments from human APP have been shown to induce amyloid deposits and progressive neurodegeneration. Therefore, it was suggested that neurotoxic effects are a specific property of human A beta. Here we show that A beta fragments derived from the Drosophila orthologue APPL aggregate into intracellular fibrils, amyloid deposits, and cause age-dependent behavioral deficits and neurodegeneration. We also show that APPL can be cleaved by a novel fly beta-secretase-like enzyme. This suggests that A beta-induced neurotoxicity is a conserved function of APP proteins whereby the lack of conservation in the primary sequence indicates that secondary structural aspects determine their pathogenesis. In addition, we found that the behavioral phenotypes precede extracellular amyloid deposit formation, supporting results that intracellular A beta plays a key role in AD. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:274 / 281
页数:8
相关论文
共 44 条
[1]
ADAMs family members as amyloid precursor protein α-secretases [J].
Allinson, TMJ ;
Parkin, ET ;
Turner, AJ ;
Hooper, NM .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 74 (03) :342-352
[2]
A cell biological perspective on Alzheimer's disease [J].
Annaert, W ;
De Strooper, B .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2002, 18 :25-51
[4]
Drosophila as a model for human neurodegenerative disease [J].
Bilen, J ;
Bonini, NM .
ANNUAL REVIEW OF GENETICS, 2005, 39 :153-171
[5]
Cloning and characterization of the Drosophila presenilin homologue [J].
Boulianne, GL ;
LivneBar, I ;
Humphreys, JM ;
Liang, Y ;
Lin, C ;
Rogaev, E ;
StGeorgeHyslop, P .
NEUROREPORT, 1997, 8 (04) :1025-1029
[6]
Preclinical Alzheimer's disease: diagnosis and prediction of progression [J].
Chong, MS ;
Sahadevan, S .
LANCET NEUROLOGY, 2005, 4 (09) :576-579
[7]
Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila [J].
Chung, HM ;
Struhl, G .
NATURE CELL BIOLOGY, 2001, 3 (12) :1129-1132
[8]
What the evolution of the amyloid protein precursor supergene family tells us about its function [J].
Coulson, EJ ;
Paliga, K ;
Beyreuther, K ;
Masters, CL .
NEUROCHEMISTRY INTERNATIONAL, 2000, 36 (03) :175-184
[9]
Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease [J].
Crowther, DC ;
Kinghorn, KJ ;
Miranda, E ;
Page, R ;
Curry, JA ;
Duthie, FAI ;
Gubb, DC ;
Lomas, DA .
NEUROSCIENCE, 2005, 132 (01) :123-135
[10]
Disruption of the MAP1B-related protein FUTSCH leads to changes in the neuronal cytoskeleton, axonal transport defects, and progressive neurodegeneration in Drosophila [J].
da Cruz, AB ;
Schwärzel, M ;
Schulze, S ;
Niyyati, M ;
Heisenberg, M ;
Kretzschmar, D .
MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (05) :2433-2442